Fluvastatin Capsules USP — Class II drug recall D-1430-2014
Terminated recall by Teva Pharmaceuticals USA, reported 2014-07-16, distributed nationwide. Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluva
| Recall number | D-1430-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, North Wales, PA, United States |
| Recall initiated | 2014-05-29 |
| Classified | 2014-07-10 |
| Reported by FDA | 2014-07-16 |
| Terminated | 2015-03-09 |
| Distributed | Nationwide (US) |
| Quantity | 8,472 bottles |
| Reason classes | device malfunction |
| NDC | 00093-7442, 00093-7442-01, 00093-7442-56, 00093-7443, 00093-7443-01, 00093-7443-56 |
| Lot numbers | F47008 |
| Expiration dates | 2015-07 |
Product
Fluvastatin Capsules USP, 20 mg, Rx Only, 30-count bottle, manufactured for Teva Pharmaceuticals, Sellersville, PA, by Teva Pharmaceutical IND LTD, Jerusalem, Israel, NDC 0093-7442-56
Reason for recall
Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1430-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.